By Tadas Baliutavicius
A patient considering treatment abroad is rarely choosing between hospitals alone. They are deciding whether to trust a clinical team they have never met, share sensitive medical information, travel to another country and commit money before they fully understand what happens next. By the time they enquire, uncertainty is already part of the journey.
Providers invest heavily in creating that first moment of interest. But an enquiry is not a consultation, a consultation is not a clinical decision, and a clinical decision is not completed treatment. Between those stages sits a less visible operational problem: what happens when interest is present, but the patient journey is not clear enough to support it?
The scale makes that question difficult to dismiss. Türkiye’s official international health-services organisation, USHAŞ, reported 563,327 health-tourism patients and approximately US$1.58 billion in related revenue for the second quarter of 2026. In June, Dubai’s health and immigration authorities announced closer coordination around medical visas and the treatment journey, including patient follow-up. Both examples point to the same reality. International healthcare growth depends on more than attracting attention.
The patient sees one journey. The provider often sees several.
Consider a patient seeking dental implants, fertility treatment or a surgical procedure abroad. Their first message arrives through WhatsApp on a Sunday evening. A coordinator replies on Monday morning with a price estimate. Someone else requests medical records. A third person discusses travel. A clinician has not yet reviewed whether treatment is appropriate.
Nothing in that sequence sounds unusual. The problem is that each handover creates room for delay, inconsistent information and uncertainty about who owns the next step.
The clinic may classify the enquiry as active. The patient may already feel abandoned.
Geography makes this easier to miss. A clinic operating on local office hours may receive enquiries from patients living several time zones away. A message answered the next morning can feel prompt internally while leaving the patient without clarity for an entire working day. Response speed only has meaning when viewed from the patient’s side.
Cross-border treatment makes those gaps more consequential. Patients are weighing clinical quality, travel arrangements, cost, language, recovery time and what happens if complications arise after they return home.
An unanswered question is not simply an administrative inconvenience. It can alter their judgement of the provider’s competence before a clinical conversation has even begun.
Ethical care must remain the boundary. Appropriate care sometimes means delaying a procedure, requesting further assessment or advising against travel altogether. The objective is to ensure that uncertainty, poor communication or a broken handover does not prevent patients from making an informed decision.
Trust breaks down in the handover
The evidence on continuity is increasingly clear. A 2026 OECD policy brief found that patients who had to repeat information already provided reported trust and experienced care quality approximately 15 percentage points lower, on average, than patients who did not. Measures of person-centred care were roughly 20 percentage points lower.
Those findings come from broader healthcare data, not a dedicated medical-tourism study. They should not be presented as a prediction of how many international patients a particular clinic will lose. They do, however, show a measurable association between fragmented information and weaker patient confidence.
In an international setting, the operational implications are straightforward. If a patient has already explained their condition to a coordinator, they should not have to restart that explanation with every new contact. If pricing is provisional, that needs to be stated clearly. If a clinical review is pending, someone should explain who is reviewing the case and when the patient can expect an answer.
Financial clarity matters too. Australia’s Department of Health opened a 2026 consultation on informed financial consent and fee transparency, linking clearer communication of healthcare charges with patient understanding and confidence. For overseas patients, uncertainty can extend beyond the procedure itself to diagnostics, accommodation, medication, revised treatment plans and follow-up care.
A low initial quote may attract an enquiry. An unclear final cost can destroy the relationship.
A full pipeline can hide a weak process
Many healthcare organisations can report how many leads an advertising campaign generated. Far fewer can explain what happened to each person afterwards.
Imagine a provider receives 200 international enquiries in a month. Of those, 120 receive meaningful two-way contact, 70 arrange consultations, 45 attend and 18 proceed to appropriate treatment. Those numbers are illustrative, not an industry benchmark. Their purpose is to show why a single conversion rate cannot explain where the journey is failing.
If most losses happen before meaningful contact, the issue may be response coverage, language or channel management. If consultations are booked but not attended, timing, reminders or uncertainty about what the appointment involves may be responsible. If patients attend but do not proceed, the explanation might be clinical suitability, incomplete information, price, financing, recovery arrangements or concern about aftercare.
These are different problems. Increasing advertising spend will not solve all of them.
The basic measurements should include time to the first meaningful response, successful contact rate, clinically appropriate qualification, consultation booking and attendance, treatment decision, time between stages and recorded reasons for disengagement. After-hours enquiries, source market, language and treatment type should also be visible, because averages can conceal problems affecting specific patient groups.
Classification matters as much as counting. A patient who declines an unsuitable procedure should not be recorded alongside someone who disappeared after three unanswered messages. One outcome reflects responsible clinical judgement; the other may expose an avoidable operational failure. Treating both as lost sales produces poor management information and encourages the wrong behaviour.
One distinction matters: an automated acknowledgement is not a meaningful response. Confirmation that a message arrived does not tell a patient whether someone understands their concern or what happens next.
Communication is part of care
In July 2026, NHS England introduced minimum standards for planned patient care that emphasise clear referral information, appointment notice, timely rebooking and communication after treatment decisions. The context is public healthcare, not medical tourism, but the principle transfers: patients need clarity about where they stand and what comes next.
For international providers, that means a named coordinator, a clear explanation of clinical review, transparent costs, agreed contact preferences and a documented aftercare plan. It also means recognising when a question requires a qualified clinician rather than leaving a sales or administrative team to offer reassurance beyond its competence.
The World Health Organization’s 2026 patient-safety guidance reinforces the same priorities: continuity, clear communication, safe handovers and follow-up across healthcare settings. Responsible care coordination depends on getting those fundamentals right.
Follow-up also needs judgement. Repeated pressure after a patient has declined treatment is not good service. A timely message addressing an unanswered question, confirming a clinical review or clarifying recovery arrangements can be.
Technology should make responsibility visible
Digital systems can help providers record enquiries, assign ownership, monitor response times and identify patients waiting for clinical information. They can also prevent a coordinator from asking for details that have already been supplied.
But software does not create trust by itself. The same OECD analysis found widespread use of electronic records alongside low patient awareness of online access. The gap illustrates a simple point: a system can exist inside an organisation without making the patient’s experience clearer.
Used properly, technology should support informed human communication. That includes secure handling of personal and clinical information, appropriate consent, clear clinical responsibility and a reliable record of what the patient has been told.
It should also make gaps visible before they become complaints: an assessment awaiting review, a consultation that was never confirmed, or a patient returning home without clear follow-up instructions. The value is not the dashboard itself, but the action somebody takes because the information is visible.
The missing middle in medical tourism lies between patient interest and informed treatment. Here, communication, coordination and accountability either hold together or fall apart.
Providers that understand that space will not only see where opportunities are being lost. They will be better placed to give patients what they are actually looking for before they travel: confidence that someone is paying attention.
About the Author
Tadas Baliutavicius is the founder of Clinivaro, a healthcare growth consultancy specialising in private healthcare and medical tourism. With more than 20 years’ experience in digital acquisition, lead generation and conversion strategy, and work spanning over £350 million in advertising spend, he focuses on how healthcare providers turn patient enquiries into consultations and treatment through better communication, follow-up and patient coordination.
Clinivaro
Clinivaro is a healthcare growth consultancy focused on patient acquisition, enquiry management, follow-up and conversion across private healthcare and medical tourism.
Website: clinivaro.com
Editorial sources
1. USHAŞ, Health Tourism Data, 2026: View source
2. Government of Dubai Media Office, GDRFA Dubai and Dubai Health Authority agreement, 2 June 2026: View source
3. OECD, Building People-Centred Digital Health Systems: Lessons from PaRIS, 2026: View source
4. Australian Government Department of Health, Fee Transparency in Health Care consultation, July-August 2026: View source
5. NHS England, Minimum Standards for Planned Patient Care, 3 July 2026: View source
6. World Health Organization, World Patient Safety Day 2026: Calls to Action and Key Messages: View source
